SC: Completed Trial can't be Remanded for Procedural Lapse Unless Prejudice is Proven  ||  SC: Sessions Courts Cannot Bar Statutory Remission and Commutation Through Special Sentences  ||  SC: Article 311 Bar Inapplicable If Removing Officer Equals Appointing Authority in Status  ||  SC: Contractual Bar Prevents Arbitral Tribunal From Awarding Pre-Reference Interest  ||  SC Frames Guidelines to Prevent POCSO Act Misuse by Parents in Custody Disputes  ||  Delhi HC Directs DLSA to Convey Trial Court’s Encouraging Message and Compensation to POCSO Survivor  ||  Delhi HC: Gravity of UAPA Offence Cannot Justify Prolonged PMLA Detention  ||  Delhi HC Affirms Equestrian Federation's Youth Olympics Selection, Calls for Clearer Norms & Timeline  ||  Delhi HC: Ajeet Bharti Used Caste Superiority to Humiliate Chandrashekhar Azad  ||  Supreme Court: Anti-Suit Injunction Cannot Rest on Speculation of Unenforceable Foreign Decree    

Competition Commission of India Levies Rs 74 Cr Fine on Himalaya Drug and Three Others - (05 Jun 2019)

MRTP/ COMPETITION LAWS

Competition Commission of India has imposed a total fine of over Rs 74 crore on Himalaya Drug Company and Intas Pharmaceuticals along with its senior officials as well as two Madhya Pradesh-based drug groupings namely Madhya Pradesh Chemists and Druggist Association and Indore Chemists Association for indulging in anti-competitive trade practices.

Tags : COMPETITION COMMISSION OF INDIA   HIMALAYA DRUG  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved